+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

Trigeminal Neuralgia Treatment Global Market Report 2025 - Product Thumbnail Image

Trigeminal Neuralgia Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Peripheral Neuritis Treatment Global Market Report 2025 - Product Thumbnail Image

Peripheral Neuritis Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Neurofibromatosis Type 1 Global Market Report 2025 - Product Thumbnail Image

Neurofibromatosis Type 1 Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Dravet Syndrome Global Market Report 2025 - Product Thumbnail Image

Dravet Syndrome Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Diabetic Peripheral Neuropathy Global Market Report 2025 - Product Thumbnail Image

Diabetic Peripheral Neuropathy Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
From
From
From
Fragile X Syndrome (FXS) Treatment Global Market Report 2025 - Product Thumbnail Image

Fragile X Syndrome (FXS) Treatment Global Market Report 2025

  • Report
  • January 2025
  • 175 Pages
  • Global
From
Trigeminal Neuralgia- Pipeline Insight, 2025 - Product Thumbnail Image

Trigeminal Neuralgia- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Diabetic Neuropathic Pain- Pipeline Insight, 2025 - Product Thumbnail Image

Diabetic Neuropathic Pain- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Status Epilepticus - Pipeline Insight, 2025 - Product Thumbnail Image

Status Epilepticus - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
Infantile Spasm Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Infantile Spasm Therapeutics - Global Strategic Business Report

  • Report
  • September 2025
  • 377 Pages
  • Global
From
Prion Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Prion Disease Treatment - Global Strategic Business Report

  • Report
  • September 2025
  • 268 Pages
  • Global
From
From
Dystonia Drugs - Global Strategic Business Report - Product Thumbnail Image

Dystonia Drugs - Global Strategic Business Report

  • Report
  • September 2025
  • 369 Pages
  • Global
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more